Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCC
Clinical trial NCT04826679 · UNKNOWN
Trial details
- NCT number
- NCT04826679
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-04-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.